Citadel Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Hold |
0
| – | – | – | 5618 |
|
|
2019
Q4 | – | Sell |
-1,017,783
| Closed | -$28.6M | – | 5390 |
|
|
2019
Q3 | $28.6M | Buy |
1,017,783
+346,020
| +52% | +$9.72M | 0.01% | 644 |
|
|
2019
Q2 | $25.4M | Buy |
671,763
+322,398
| +92% | +$12.2M | 0.01% | 679 |
|
|
2019
Q1 | $13.6M | Sell |
349,365
-714,485
| -67% | -$27.9M | 0.01% | 932 |
|
|
2018
Q4 | $22.7M | Buy |
1,063,850
+522,154
| +96% | +$11.1M | 0.01% | 625 |
|
|
2018
Q3 | $21.4M | Buy |
541,696
+137,021
| +34% | +$5.42M | 0.01% | 728 |
|
|
2018
Q2 | $15.5M | Buy |
+404,675
| New | +$15.5M | 0.01% | 829 |
|
|
2018
Q1 | – | Sell |
-339,588
| Closed | -$10.6M | – | 4620 |
|
|
2017
Q4 | $10.6M | Buy |
339,588
+228,667
| +206% | +$7.15M | 0.01% | 928 |
|
|
2017
Q3 | $3.11M | Buy |
110,921
+100,663
| +981% | +$2.82M | ﹤0.01% | 1573 |
|
|
2017
Q2 | $196K | Sell |
10,258
-557
| -5% | -$10.6K | ﹤0.01% | 3176 |
|
|
2017
Q1 | $184K | Buy |
+10,815
| New | +$184K | ﹤0.01% | 3208 |
|